SCM
STOK icon

Sio Capital Management’s Stoke Therapeutics STOK Stock Holding History

Sio Capital Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-175,301
Closed -$2.37M – 54
2024
Q2 		$2.37M Sell
175,301
-50,195
-22% -$678K 0.64% 27
2024
Q1 		$3.04M Buy
+225,496
New +$1.37M 0.91% 32

Other funds holding STOK

ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sio Capital Management's STOK Position: Q3 2024 in Review

Sio Capital Management sold out of Stoke Therapeutics (STOK) in Q3 2024, closing a stake of 175,301 shares — an estimated $2.37M sold.

Sio Capital Management first reported a position in STOK in Q1 2024 and held it in 2 quarters. The position peaked at $3.04M in Q1 2024. 118 funds tracked by Wall St. Rank hold STOK as of Q3 2024.

  • Sio Capital Management reported no remaining Stoke Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Sio Capital Management sold 175,301 Stoke Therapeutics shares in Q3 2024, an estimated $2.37M.
  • Sio Capital Management first reported a position in Stoke Therapeutics in Q1 2024 and held it in 2 quarters.
  • Sio Capital Management's Stoke Therapeutics position peaked at $3.04M in Q1 2024.
  • 118 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2024.

Based on Sio Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.